drugset / Trial / NCT00618007
Effect of PF-00734200 in Subjects With Type 2 Diabetes
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine the effect of PF-00734200 on HbA1c in type 2 diabetic subjects receiving metformin
Timeline
- Start
- 2008-02
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gosogliptin | Small molecule | 20 mg | — |
| Subject | Gosogliptin | Small molecule | 30 mg | — |